Santen Pharmaceutical Advances Governance and Diversity

Santen Pharmaceutical Co (JP:4536) has released an update.

Santen Pharmaceutical Co. is committed to enhancing its corporate governance to improve corporate value and shareholder returns, utilizing Japan’s ‘Company with Board of Corporate Auditors’ system. The company’s board actively incorporates outside directors’ experience and oversees strategic shareholdings to ensure they contribute to business growth, recently divesting from four brands to optimize its investment portfolio. Furthermore, Santen emphasizes diversity in its workforce, aiming to create an inclusive environment that contributes to organizational excellence and aligns with its sustainability strategy.

For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.